Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study

Chin Med J (Engl). 2022 Sep 5;135(17):2134-2136. doi: 10.1097/CM9.0000000000002243.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter

MeSH terms

  • Benzodiazepines*
  • Humans
  • Hypnotics and Sedatives / therapeutic use
  • Intensive Care Units
  • Midazolam*

Substances

  • Benzodiazepines
  • Hypnotics and Sedatives
  • Midazolam
  • remimazolam